#Novavax
Health & Fitness | Coronavirus COVID19
FDA Flags Heart Inflammation Risk Over Novavax COVID-19 Vaccine
Staff with the U.S. Food and Drug Administration (FDA) on Friday flagged the risk of heart inflammation following ...
Health & Fitness | Coronavirus COVID19
Novavax COVID-19 Vaccine May Be Issued Emergency Use Authorization in June: FDA
The U.S. Food and Drug Administration (FDA) announced Friday that it will have its advisory panel meet to ...
Health & Fitness | Coronavirus COVID19
Novavax's COVID vaccine rollout in EU off to a slow start
Demand for the COVID-19 vaccine produced by U.S. biotech firm Novavax has been underwhelming in the European Union's main countries in the early rollout, so far undermining hopes that it could convince vaccine sceptics to get a shot.
Health & Fitness | Coronavirus COVID19
Novavax at 'tipping point' with COVID vaccine: CEO
Novavax CEO Stanley Erck said that his company is at the “tipping point” as it pertains to its COVID vaccine and noted that the two-dose series will be “very effective” against the highly-contagious omicron strain.
Health & Fitness | Coronavirus COVID19
Moderna or Novavax after AstraZeneca jab confers high Covid immunity, study finds
Finding is good news for lower-income countries that have not yet completed their primary vaccination campaigns
Health & Fitness | Coronavirus COVID19
Novavax completes process for WHO emergency use approval of COVID-19 vaccine
Vaccine developer Novavax Inc said on Thursday it has completed the submission process for emergency use listing of its COVID-19 vaccine candidate with the World Health Organization.
Health & Fitness | Coronavirus COVID19
Novavax Statement on CDC Guidance Update for COVID-19 Clinical Trial Participants
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that the U.S. Centers for Disease Control and Prevention (CDC) has provided updated guidance for those who have been
Health & Fitness | Coronavirus COVID19
Novavax again delays seeking U.S. approval for COVID-19 vaccine
Novavax Inc on Thursday again delayed its timeline for seeking U.S. authorization for its two-dose COVID-19 vaccine but expects to become a major distributor to lower and middle-income countries this year.
Health & Fitness | Coronavirus COVID19
The mRNA Vaccines Are Extraordinary, but Novavax Is Even Better
Persistent hype around mRNA vaccine technology is now distracting us from other ways to end the pandemic.
